AFAP1 and nasopharyngeal carcinoma: Kaplan-Meier survival assays (Figure 1E) demonstrated that NPC patients with higher AFAP1-AS1 expression levels had lower overall survival rates than patients with lower AFAP1-AS1 expression levels.